These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31642904)

  • 61. Targeting phosphodiesterase 4 as a potential therapeutic strategy for enhancing neuroplasticity following ischemic stroke.
    Wang H; Gaur U; Xiao J; Xu B; Xu J; Zheng W
    Int J Biol Sci; 2018; 14(12):1745-1754. PubMed ID: 30416389
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Regulation of cAMP-specific phosphodiesterases type 4B and 4D (PDE4) splice variants by cAMP signaling in primary cortical neurons.
    D'Sa C; Tolbert LM; Conti M; Duman RS
    J Neurochem; 2002 May; 81(4):745-57. PubMed ID: 12065634
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Arrestin-dependent localization of phosphodiesterases.
    Willis MJ; Baillie GS
    Handb Exp Pharmacol; 2014; 219():293-307. PubMed ID: 24292836
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1).
    MacKenzie SJ; Baillie GS; McPhee I; MacKenzie C; Seamons R; McSorley T; Millen J; Beard MB; van Heeke G; Houslay MD
    Br J Pharmacol; 2002 Jun; 136(3):421-33. PubMed ID: 12023945
    [TBL] [Abstract][Full Text] [Related]  

  • 65. FFPM, a PDE4 inhibitor, reverses learning and memory deficits in APP/PS1 transgenic mice via cAMP/PKA/CREB signaling and anti-inflammatory effects.
    Guo H; Cheng Y; Wang C; Wu J; Zou Z; Niu B; Yu H; Wang H; Xu J
    Neuropharmacology; 2017 Apr; 116():260-269. PubMed ID: 28065587
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dominant-Negative Attenuation of cAMP-Selective Phosphodiesterase PDE4D Action Affects Learning and Behavior.
    Bolger GB; Smoot LHM; van Groen T
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784895
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Selective phosphodiesterase (PDE)-4 inhibitors: a novel approach to treating memory deficit?
    Ghavami A; Hirst WD; Novak TJ
    Drugs R D; 2006; 7(2):63-71. PubMed ID: 16542053
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identification of a multifunctional docking site on the catalytic unit of phosphodiesterase-4 (PDE4) that is utilised by multiple interaction partners.
    Houslay KF; Christian F; MacLeod R; Adams DR; Houslay MD; Baillie GS
    Biochem J; 2017 Feb; 474(4):597-609. PubMed ID: 27993970
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Regulation of murine cardiac function by phosphodiesterases type 3 and 4.
    Beca S; Aschars-Sobbi R; Panama BK; Backx PH
    Curr Opin Pharmacol; 2011 Dec; 11(6):714-9. PubMed ID: 22047792
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
    Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A
    Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238
    [TBL] [Abstract][Full Text] [Related]  

  • 71. PET measurements of cAMP-mediated phosphodiesterase-4 with (R)-[11C]rolipram.
    Kenk M; Thomas A; Lortie M; Dekemp R; Beanlands RS; Dasilva JN
    Curr Radiopharm; 2011 Jan; 4(1):44-58. PubMed ID: 22191614
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Expression of the cAMP-phosphodiesterase PDE4D isoforms and age-related changes in follicle-stimulating hormone-stimulated PDE4 activities in immature rat sertoli cells.
    Levallet G; Levallet J; Bouraïma-Lelong H; Bonnamy PJ
    Biol Reprod; 2007 May; 76(5):794-803. PubMed ID: 17215491
    [TBL] [Abstract][Full Text] [Related]  

  • 73. RNA interference-mediated knockdown of long-form phosphodiesterase-4D (PDE4D) enzyme reverses amyloid-β42-induced memory deficits in mice.
    Zhang C; Cheng Y; Wang H; Wang C; Wilson SP; Xu J; Zhang HT
    J Alzheimers Dis; 2014; 38(2):269-80. PubMed ID: 23948935
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The role of ERK2 docking and phosphorylation of PDE4 cAMP phosphodiesterase isoforms in mediating cross-talk between the cAMP and ERK signalling pathways.
    Houslay MD; Baillie GS
    Biochem Soc Trans; 2003 Dec; 31(Pt 6):1186-90. PubMed ID: 14641023
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A CaMKII/PDE4D negative feedback regulates cAMP signaling.
    Mika D; Richter W; Conti M
    Proc Natl Acad Sci U S A; 2015 Feb; 112(7):2023-8. PubMed ID: 25646485
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Optimization and validation of a reporter gene assay for screening of phosphodiesterase inhibitors in a high throughput system.
    Nanda K; Chatterjee M; Arya R; Mukherjee S; Saini KS; Dastidar S; Ray A
    Biotechnol J; 2008 Oct; 3(9-10):1276-9. PubMed ID: 18655041
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Phosphodiesterase 4B: Master Regulator of Brain Signaling.
    Tibbo AJ; Baillie GS
    Cells; 2020 May; 9(5):. PubMed ID: 32438615
    [TBL] [Abstract][Full Text] [Related]  

  • 78. PDE4 subtypes in cancer.
    Hsien Lai S; Zervoudakis G; Chou J; Gurney ME; Quesnelle KM
    Oncogene; 2020 May; 39(19):3791-3802. PubMed ID: 32203163
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Role of Cyclic AMP Signaling in Cardiac Fibrosis.
    Delaunay M; Osman H; Kaiser S; Diviani D
    Cells; 2019 Dec; 9(1):. PubMed ID: 31888098
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Moderate-Intensity Intermittent Training Alters the DNA Methylation Pattern of PDE4D Gene in Hippocampus to Improve the Ability of Spatial Learning and Memory in Aging Rats Reduced by D-Galactose.
    Zhang J; Gao Q; Gao J; Lv L; Liu R; Wu Y; Li X; Jin Y; Wang L
    Brain Sci; 2023 Feb; 13(3):. PubMed ID: 36979232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.